Trial Profile
Efficacy of Intravenous Iron Therapy in Maintaining Hemoglobin Concentration on Patients Undergoing Bimaxillary Orthognathic Surgery
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric derisomaltose (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 15 Mar 2019 Planned End Date changed from 1 Feb 2019 to 1 Aug 2019.
- 15 Mar 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Aug 2019.
- 17 May 2018 Planned End Date changed from 1 Sep 2018 to 1 Feb 2019.